Dear User,
On May 25, 2018, Regulation (EU) 2016/679 of the European Parliament and of the Council of April 27, 2016 (General Data Protection Regulation) came into force. We encourage you to familiarise yourself with information about the processing of personal data on the PolskieRadio.pl website.
1.The Data Administrator is Polish Radio S.A., based at 77/85 Niepodległości Ave., 00-977, Warsaw.
2.On issues regarding your data, please contact the Data Protection Officer, e-mail: iod@polskieradio.pl, tel. 22 645 34 03.
3.Personal data may be processed for marketing purposes based on consent.
4.Personal data may be shared solely for the purpose of proper implementation of services defined in the privacy policy.
5.Personal data will not be transferred outside the European Economic Area or to an international organisation.
6.Personal data will be stored for 5 years after an account is deactivated, in accordance with the law.
7.You have the right to access your personal data, correct it, to have it moved or deleted, or to limit its processing.
8.You have the right to object to further processing, and in the case of voicing consent to the processing of personal data, you have the right to withdraw your consent. The exercise of the right to withdraw consent does not affect any processing that has already taken place.
9.You have the right to lodge a complaint with the supervisory authority.
10.Polish Radio S.A. declares that no automated decisions are made when personal data is processed, and that profiling is not used.
For more information on this subject, please read our personal data and privacy policy.
English Section

Polish PM, AstraZeneca execs discuss COVID-19 vaccine

16.11.2020 07:30
Poland's Prime Minister Mateusz Morawiecki has talked with executives from global pharmaceutical company AstraZeneca amid efforts to secure a COVID-19 vaccine for Poles as soon as possible, state news agency PAP has reported.

AstraZeneca said in a statement that the talks at the end of last week focused on collaboration in the fight against the COVID-19 pandemic in Poland, including joint efforts to ensure access to a COVID-19 vaccine.

The company said on its website that it was pursuing research and development work to develop a COVID-19 vaccine in conjunction with the University of Oxford.

“Data from phases 1 and 2 of clinical trials are promising, and we are now entering advanced phases of research in many countries,” AstraZeneca’s Chairman Leif Johansson was quoted, in Polish, as saying.

“Our priority is to deliver an effective and safe vaccine, and to work with governments and international organizations to ensure widespread and equitable access to vaccination for patients around the world.”

The Polish prime minister was cited as saying that his government “will continue to work with AstraZeneca and other entities working on a COVID-19 vaccine to provide Polish patients with a safe and effective vaccine as soon as possible.”

“During the meeting, we reaffirmed our cooperation in the fastest possible distribution of a potential vaccine once it is registered and brought to market,” Morawiecki said, as quoted on the astrazeneca.pl website.

Polish Prime Minister Mateusz Morawiecki holds a remote meeting with executives from UK-based based drug company AstraZeneca on Friday, November 2020. Photo: Krystian Maj/KPRM Polish Prime Minister Mateusz Morawiecki holds a remote meeting with executives from UK-based based drug company AstraZeneca on Friday, November 2020. Photo: Krystian Maj/KPRM

Another topic of Friday’s videoconference, which was also attended by Poland’s Health Minister Adam Niedzielski, was AstraZeneca's investment in the country, according to the company’s website.

The UK-based drug maker in January announced plans to invest PLN 1.5 billion (EUR 350 million, USD 390 million) in Poland over the next five years.

That announcement followed a meeting between Morawiecki and Johansson at the World Economic Forum in Davos, Switzerland.

The Polish prime minister said on Friday his government has set up a working group with experts from US pharmaceutical firm Pfizer amid efforts to make a coronavirus vaccine available to Poles as quickly as possible.

Morawiecki on Friday held talks with Pfizer executives after the European Union earlier last week struck a deal to buy up to 300 million doses of a potential coronavirus vaccine from the American pharmaceutical giant.

Morawiecki said last Monday that millions of vaccines against the coronavirus were likely to reach his country next spring.

He added that the vaccines would be made available to citizens on an optional basis and be first administered to senior citizens, healthcare professionals and law enforcement personnel.


Source: PAP, astrazeneca.plpremier.gov.pl